Ckd&dm: Predictors of Chronic Kidney Disease Among Type 2 Diabetic Patients in Assiut University Hospitals

Sponsor
Assiut University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05847400
Collaborator
(none)
200
1
1
196.4

Study Details

Study Description

Brief Summary

Predictors of Chronic Kidney Disease among Type 2 Diabetic Patients in Assiut University Hospitals.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Globally, the total number of people with diabetes is estimated to increase from 415 million (8.8%) in 2015 to 642 million (10.4%) in 2040, with the largest alterations expected to occur in the urban population of low- to middle-income countries (LMICs)1. Of them, type 2 diabetes mellitus (T2DM) accounts for more than 90% of people with diabetes2,3. By 2040, the difference worldwide is projected to broaden, with 477.9 million affected people living in urban areas and 163.9 million in rural areas1. It has been postulated that the burden of diabetes and its complications in the LMICs may be contributed by the economic development and rapid urbanisation via increased caloric intake and the adoption of a sedentary lifestyle2,4,5. More importantly, the most striking demo graphic change to diabetes prevalence in global terms also seems to be related to the growth of the proportion of the elderly population6. Despite rates of diabetes-related complications such as CVDs decreasing significantly in the past two decades, it has not translated nearly as well as kidney complications7. Approximately 10% of deaths in people with T2DM are attributable to kidney failure8. It is well-established that diabetes-related chronic kidney disease (CKD) is the leading cause of end-stage kidney disease (ESKD) in T2DM patients worldwide9,10.

    In our study, we aim to identify and classify patients attending diabetic outpatient clinic with both CKD and

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Predictors of Chronic Kidney Disease Among Type 2 Diabetic Patients in Assiut University Hospitals
    Anticipated Study Start Date :
    Mar 1, 2024
    Anticipated Primary Completion Date :
    Mar 28, 2024
    Anticipated Study Completion Date :
    Apr 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    CKD patients with T2DM on regular HD

    CKD patients with T2DM attending Assuit university diabetic outpatients clinic and ESRD on regular HD at dialysis unit of Assuit University Hospital

    CKD patients with T2DM not on regular HD

    CKD patients with T2DM attending Assuit university diabetic outpatients clinic and ESRD not on regular HD at dialysis unit of Assuit University Hospital

    Outcome Measures

    Primary Outcome Measures

    1. predictors of CKD among T2DM patients attending Assiut University Hospitals. To classify our patients into stages according to KDIGO guidelines [3 years]

      To identify predictors of CKD among T2DM patients attending Assiut University Hospitals. To classify our patients into stages according to KDIGO guidelines

    Secondary Outcome Measures

    1. the possible risk factors contributing to progessing CKD in T2DM patients. [3 years]

      To identify the possible risk factors contributing to progessing CKD in T2DM patients.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with T2DM aged 18 years or older. For patients whom eGFR values < or =60 ml/min/1.73m2.

    Patient with type 2 DM and ESRD on regular HD with duration less than 1 year

    Exclusion Criteria:

    Having kidney transplantation incomplete data on glycemic control. Patients with type 2 DM and ESRD on regular HD with duration more than 1 year. Pregnant woman. Patients with advanced comorbides(cardiac, hepatic,

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Assiut Assiut Egypt 088

    Sponsors and Collaborators

    • Assiut University

    Investigators

    • Principal Investigator: Muhammed Al Abualsaud, Assiut University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Muhammed Ali Aboalsaud, Aboalsaud, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05847400
    Other Study ID Numbers:
    • ckd in tybe 2 dm
    First Posted:
    May 6, 2023
    Last Update Posted:
    May 6, 2023
    Last Verified:
    Apr 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 6, 2023